Committees and groups

The Natural Therapies Review Expert Advisory Panel (NTREAP) supported the Natural Therapies Review 2024. The final meeting was held on 10 December 2024.

The Nurse Practitioner Steering Committee (NPSC) provided advice and expertise on the development of the Nurse Practitioner Workforce Plan.

The Nursing and Midwifery Strategic Reference Group (NMSRG) provides advises on relevant nursing and midwifery policy and strategy issues to the Department of Health, Disability and Ageing through the Office of the Chief Nursing and Midwifery Officer Division.

Learn about the tribunal’s role in determining how much pharmacists are paid for dispensing medicines.

The Polio Expert Panel (PEP) is a subcommittee of the Communicable Diseases Network Australia (CDNA). It reviews clinical and laboratory data from notified AFP cases to determine if cases are poliomyelitis or non-polio acute flaccid paralysis.

This Expert Advisory Panel (EAP) advised on research investments under the Medical Research Future Fund (MRFF) to improve outcomes for people experiencing Post-Acute Sequelae of COVID-19 (PASC). PASC is also known as Long COVID.

We established this taskforce within our department to advise the government on how to respond to recent primary care and workforce reviews. The taskforce works with stakeholders to design and coordinate options for responses based on recommendations from the reviews.

The Primary Health Reform Steering Group provided independent expert advice to guide the development of the Primary Health Care 10 Year Plan. The group ran from October 2019 to September 2021.

The Primary Health Research Plan Expert Advisory Panel (EAP) advised on primary health care research investments under the Medical Research Future Fund (MRFF).

Ms Christine Morgan is the first National Suicide Prevention Adviser, reporting directly to the Prime Minister. She is driving a whole-of-government national approach to suicide prevention, in support of the Australian Government’s ‘towards zero’ suicides goal.

The Private Health Chief Executive Officer Forum (CEO Forum) has been established to identify and develop short and medium-term options to support the sector’s long-term sustainability so that it can continue to serve the health care needs of Australian patients.

This committee looked at all aspects of private health insurance and provided advice about reforms to the Australian Government.

The Prostheses List Reform Governance Group monitors and reviews the Strategic Agreement with the Medical Technology Association of Australia (MTAA).

The Psychosocial Project Group is developing a plan for future arrangements for providing psychosocial supports outside the National Disability Insurance Scheme.

The Public Health Laboratory Network (PHLN) is Australia’s leading network of public health laboratories that have expertise and provide services in public health microbiology in Australia.

The Quality Use of Pathology Committee provides advice on the Quality Use of Pathology Program (QUPP).

The RAC Funding Reform Working Group advises the Department of Health, Disability and Ageing on residential aged care funding reform activities.

The Roadmap Implementation Governance Group oversees the implementation of the national roadmap for improving the health of people with intellectual disability.

The Senior Officer Group (SOG) oversee the implementation of the 2021–22 Budget measure to align provider regulation across the care and support sectors.

The partnership brings together First Nations and government representatives. It aims to improve social and emotional wellbeing and mental health and reduce suicide rates.

The Stem Cell Therapies Mission Expert Advisory Panel (EAP) advised the government on the research priorities for this mission, which is funded by the Medical Research Future Fund (MRFF).

The Stoma Product Assessment Panel assesses applications to add stoma products to the Stoma Appliance Scheme Schedule. The panel of experts meets twice a year to review applications from suppliers, and give their recommendation.

This committee guides the implementation of Strengthening Medicare reform measures. It consists of peak bodies, industry leaders, consumer representatives, experts from across the sector and jurisdictional representatives.

The Minister for Health and Aged Care established the Strengthening Medicare Taskforce to provide recommendations on the highest priority improvements to primary care.

The Targeted Translation Research Accelerator Plan Expert Advisory Panel (EAP) advised on investments under the Medical Research Future Fund (MRFF) for research into diabetes and cardiovascular disease.